Literature DB >> 17512528

Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression.

Natalia Guiñazú1, Andrea Pellegrini, Eugenio Antonio Carrera-Silva, Maria Pilar Aoki, Ana Maria Cabanillas, Nuria Gìronés, Manuel Fresno, Roxana Cano, Susana Gea.   

Abstract

Innate and adaptive immunity collaborate in the protection of intracellular pathogens including Trypanosoma cruzi infection. However, the parasite molecules that regulate the host immune response have not been fully identified. We previously demonstrated that the immunisation of C57BL/6 mice with cruzipain, an immunogenic T. cruzi glycoprotein, induced a strong specific T-cell response. In this study, we demonstrated that active immunisation with cruzipain was able to stimulate nitric oxide (NO) production by splenocytes. Immune cells also showed increased inducible nitric oxide synthase protein and mRNA expression. Spleen adherent cells secreted high levels of IFN-gamma and IL-12. Microbicidal activity in vitro was mainly mediated by reactive nitrogen intermediaries and IFN-gamma, as demonstrated by the inhibitory effects of NO synthase inhibitor or by IFN-gamma neutralisation. Specific T-cells were essential for NO, IFN-gamma and TNF-alpha production. Furthermore, we reported that cruzipain enhanced CD80 and major histocompatibility complex-II molecule surface expression on F4/80+ spleen cells. Interestingly, we also showed that cruzipain up-regulated toll like receptor-2 expression, not only in F4/80+ but also in total spleen cells which may be involved in the effector immune response. Our findings suggest that a single parasite antigen such as cruzipain, through adaptive immune cells and cytokines, can modulate the macrophage response not only as antigen presenting cells, but also as effector cells displaying enhanced microbicidal activity with reactive nitrogen intermediary participation. This may represent a mechanism that contributes to the immunoregulatory process during Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512528     DOI: 10.1016/j.ijpara.2007.03.010

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  6 in total

1.  Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity.

Authors:  María Noel Alvarez; Gonzalo Peluffo; Lucía Piacenza; Rafael Radi
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

Review 2.  Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead.

Authors:  Kevin M Bonney; David M Engman
Journal:  Am J Pathol       Date:  2015-04-07       Impact factor: 4.307

3.  Nonimmune Cells Contribute to Crosstalk between Immune Cells and Inflammatory Mediators in the Innate Response to Trypanosoma cruzi Infection.

Authors:  Maria Pilar Aoki; Eugenio Antonio Carrera-Silva; Henar Cuervo; Manuel Fresno; Núria Gironès; Susana Gea
Journal:  J Parasitol Res       Date:  2011-08-18

4.  Polysaccharide from black currant (Ribes nigrum L.) stimulates dendritic cells through TLR4 signaling.

Authors:  Hiroshi Ashigai; Yuta Komano; Guanying Wang; Yasuji Kawachi; Kazuko Sunaga; Reiko Yamamoto; Ryoji Takata; Mika Miyake; Takaaki Yanai
Journal:  Biosci Microbiota Food Health       Date:  2017-07-04

Review 5.  Interactions between Trypanosoma cruzi Secreted Proteins and Host Cell Signaling Pathways.

Authors:  Renata Watanabe Costa; Jose F da Silveira; Diana Bahia
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

6.  Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Trypanosoma cruzi Infection.

Authors:  María Belén Antonoglou; Andrés Sánchez Alberti; Daniela María Redolfi; Augusto Ernesto Bivona; María Julieta Fernández Lynch; Sofía Noli Truant; María Belén Sarratea; Laura Valeria Iannantuono López; Emilio Luis Malchiodi; Marisa Mariel Fernández
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.